PATENT CLAIM ANALYSIS

Application Number: 16081543
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["514", "415000"]

Abstract:
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for the treatment of lysine (K)-specific demethylase 1A (LSD1)-mediated diseases or disorders: wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6  are as defined herein.

Claim (Index 17):
The method of  claim 16  wherein said disease or disorder is selected from B cell lymphoma, acute myeloid leukemia, gastric cancer, hepatocellular carcinoma, prostate cancer, breast carcinoma, neuroblastoma, glioblastoma, nasopharyngeal carcinoma, colon cancer, gallbladder cancer, esophageal cancer, head and neck cancer, lung cancer, ovarian cancer, pancreatic cancer, endometrial carcinoma and soft tissue sarcomas, Ewing's sarcoma, liver fibrosis, and sickle cell disease.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 96.0
- Lexical Diversity: 1.34
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16012468', '14977273', '16311575', '15538348', '16311621']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7674707549058614
- 35 USC 102 Novelty (BERT): 0.5647259167148648
- Combined Prediction Score: 0.7471962710867617
- Mean Citation Score: 354.638328
- Max Citation Score: 418.77243
- Similarity Product: 400.355266816256

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test